RT Journal Article
SR Electronic
T1 Young onset diabetes in Asian Indians is associated with lower measured and genetically determined beta-cell function: an INSPIRED study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.07.21263208
DO 10.1101/2021.09.07.21263208
A1 Siddiqui, Moneeza K
A1 Anjana, RM
A1 Dawed, Adem Y
A1 Martoeau, Cyrielle
A1 Srinivasan, Sundararajan
A1 Saravanan, Jebarani
A1 Madanagopal, Sathish K
A1 Veluchamy, Abirami
A1 Pradeepa, Rajendra
A1 Sattar, Naveed
A1 Venkatesan, Radha
A1 Palmer, Colin N A
A1 Pearson, Ewan R
A1 Mohan, Viswanathan
YR 2021
UL http://medrxiv.org/content/early/2021/09/12/2021.09.07.21263208.abstract
AB Background South Asians have higher risk of type 2 diabetes compared to white Europeans and a younger age of onset. Reasons for the younger age of onset in relation to beta-cell function and insulin sensitivity are under-explored.Methods Two cohorts of Asian Indians, ICMR-INDIAB (Indian Council of Medical Research-INdia DIABetes Study) and DMDSC (Dr. Mohan’s Diabetes Specialties Centre) and one of white Europeans, ESDC (East Scotland Diabetes Cohort) were used. We examined the comparative prevalence of healthy, overweight, and obese BMI in young onset diabetes. We explored the role of clinically measured beta-cell function in diabetes onset in Asian Indians. Finally, the comparative distribution of a partitioned polygenic score (pPS) for risk of diabetes due to poor beta cell function was examined.Results Prevalence of young onset with normal BMI was 9.3% amongst white Europeans and 24%-39% amongst Asian Indians. In young diagnosed Asian Indians, after adjustment for family history of T2DM, sex, insulin sensitivity and HDL-c, stimulated C-peptide was 492pmol/mL (IQR: 353,616,P<0.0001) lower in lean compared to obese individuals. Asian Indians have lower genetically determined beta-cell function than white Europeans(P <0.0001). The pPS was associated with age of diagnosis in Asian Indians but not in white Europeans. The pPS explained 2% of variation in clinically measured beta cell function and 1.2%, 0.97%, and 0.36% of variance in age of diabetes amongst Asian Indians with normal, overweight, and obese BMI respectively.Conclusions Asian Indians have over two times the prevalence of lean BMI in young onset diabetes compared to white Europeans. This phenotype of lean, young onset diabetes appears driven in part by lower beta cell function. We demonstrate that Asian Indians with diabetes also have lower genetically determined beta cell function.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the National Institute for Health Research (NIHR) (INSPIRED 16/136/102) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical committee approvals: India: NIHR Global Health Research Unit on Global Diabetes Outcomes Research, Institutional Ethics Committee of Madras Diabetes Research Foundation, Chennai, India. IRB number IRB00002640. Granted 24th August 2017. Tayside, Scotland: Ethical approval for the study was provided by the Tayside Medical Ethics Committee (REF:053/04) and the study has been carried out in accordance with the Declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are available subject to approval by the GoDARTS data access committee and to the Madras Diabetes Research Foundation and can be made by contacting the corresponding authors.